BullFrog AI Shares Strategic Progress and Outlook with Shareholders
BullFrog AI (BFRG) has announced it has secured sufficient funding to execute its strategy through late 2027 and is in active discussions with major pharmaceutical and biotechnology firms. The company also signed its first agreement with a top 5 global pharmaceutical company, signaling progress in its AI-driven drug discovery efforts.
Topics: AI drug discovery capital runway pharmaceutical partnerships shareholder letter